FDA Approves Pfizer & Moderna's Updated COVID-19 Jabs

The FDA, on Aug 22, approved/authorized the updated mRNA-based COVID-19 vaccines of Pfizer (PFE) /BioNTech (BNTX) and Moderna (MRNA) that target the KP.2 strain of the virus.While the agency approved Pfizer/BioNTech’s Comirnaty and Moderna’s Spikevax for use in individuals aged 12 years of age and older, it granted emergency use authorization (EUA) to low-dose formulations of these vaccines for use in individuals aged six months through 11 years.These approvals/authorizations are based on a combination of m ...